Whiff of doubt: is inhaled isopropyl alcohol (alcohol wipes) an effective treatment for acute nausea in the emergency department?
In brief
Inhaled isopropyl alcohol gives rapid relief of acute ED nausea
A review of six studies found that sniffing isopropyl alcohol quickly eases nausea in adult emergency patients and can lower the need for standard anti-emetic drugs, while being cheap and well tolerated. However, none of the trials included pregnant women, so safety and effectiveness in pregnancy remain unknown.
- Journal
- Emergency medicine journal : EMJ (Q1)
- Published
- 7 September 2026
- Study design
- Randomized controlled trial
- Evidence level
- Level 1, High (CEBM 1b)
- Authors
- Joshua Khamesi, Rasha Dabis
- PMID
- 42705904
- DOI
- 10.1136/emermed-2026-216455
Why clinicians should know about it
- Picked for Emergency Medicine (top studies of the week, 13 September 2026): Rapid nausea relief, ED‑focused non‑pharmacologic treatment
Abstract
A short evidence review was conducted to evaluate whether inhaled isopropyl alcohol (IPA) is an effective non-pharmacological treatment for acute nausea in adults presenting to the emergency department (ED). MEDLINE, EMBASE and the Cochrane Library were searched from database inception to the date of search using controlled subject headings and free-text terms. Following screening, six relevant studies were identified, comprising two systematic reviews/meta-analyses, two randomised controlled trials and two implementation studies. Current evidence suggests that inhaled IPA provides rapid short-term relief of acute nausea and may reduce the need for conventional antiemetics. Implementation studies further demonstrate that IPA can be administered rapidly, reduce treatment costs and integrate effectively as a simple, self-directed intervention within ED care pathways. Importantly, no included study evaluated nausea and vomiting of pregnancy or hyperemesis gravidarum, and several studies explicitly excluded pregnant patients. Although inhaled IPA appears to be an inexpensive, readily available and well-tolerated intervention for acute nausea in the ED, its efficacy and safety during pregnancy remain unknown. Well-designed pregnancy-specific randomised controlled trials are required before its use can be recommended in pregnancy.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.